Skip to content

The efficacy of insulated microneedle radiofrequency in Keratosis pilaris

The efficacy of insulated microneedle radiofrequency in Keratosis pilaris

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210412005
Enrollment
20
Registered
2021-04-12
Start date
2021-03-03
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratosis pilaris patients in Srinakharinwirot university skin center with lesion on upper outer of arm at the age of 18-50 years old. The patients who enroll the intervention must comply the research regulations and conductions with inform consent process. Exclusion criteria is to qualify in any of the disqualification. For examples

Interventions

Monopolar insulated microneedle 6 MHz Radiofrequency (AcGen, Jeisys Medical Inc., Korea) 1.5 mm. needle tip length, 7 Watts energy, pulse duration 2 seconds, Delay time 2 seconds is performed in proce
Monopolar insulated microneedle radiofrequency

Sponsors

Faculty of Medicine, Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Keratosis pilaris patients in Srinakharinwirot university skin center with lesion on upper outer of arm at the age of 18-50 years old. The patients who enroll the intervention must comply the research regulations and conductions with inform consent process.

Exclusion criteria

Exclusion criteria: Exclusion criteria is to qualify in any of the disqualification. For examples; the COVID-19 patient, implantable medical device patient, metal implantable medical device patient, severe heart diseases, active or recent history of malignancy, immune suppression, history of topical retinoid, topical steroid, topical salicylic acid, topical lactic acid, vitamin D analogs in past 4 weeks, history of laser or radiofrequency in past 6 months, history of keratinization drugs such as steroids, Isotretinoin and Acitretin in past 6 months, photosensitivity such as SLE, Connective tissue disease, Autoimmune diseases, history of wax or hair removal procedure on upper arm in past 4 weeks, pregnancy, breastfeeding, psychosis, sunburn or wound and scar in the upper arm

Design outcomes

Primary

MeasureTime frame
Skin roughness 0,4,8,12 weeks Antera 3D, Quartile grading scale, Mean change and percent change

Secondary

MeasureTime frame
Skin erythema 0,4,8,12 weeks Antera 3D, Quartile grading scale, Mean change and percent change,Skin hyperpigmentation 0,4,8,12 weeks Antera 3D, Quartile grading scale, Mean change and percent change,Physician grading scale 0,4,8,12 weeks Quartile grading scale of physician grading scale,Visual analog scale 0, 12 weeks Visual analog scale, Side effects 0,4,8,12 weeks Observation, Chi-square Test

Countries

Thailand

Contacts

Public ContactSitraporn Binsirawanich

Srinakharinwirot university skin center

Sitrapornbn@gmail.com022594260

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026